Kaempferol Absorption and Pharmacokinetics Evaluation

Inclusion Criteria: Adults aged 18 to 70 years * Healthy volunteers as determined by medical history and screening assessment * Ability to understand the study procedures and provide informed consent * Willingness and ability to comply with all study procedures, including dietary restrictions, clinic visits, blood draws, urine collection, and follow-up assessments * Willingness to abstain from restricted foods, beverages, and supplements as specified in the study protocol during the study period Exclusion Criteria: * Known allergy or hypersensitivity to Kaempferol or related flavonoids * Pregnancy or breastfeeding * Presence of significant acute or chronic medical conditions that could increase risk or interfere with study outcomes, including but not limited to: * Active or chronic infections * Cancer * Cardiovascular disease * Neurological or neurodegenerative disorders * Metabolic or systemic inflammatory conditions * Use of prescription medications or supplements known to interfere with Kaempferol metabolism or pharmacokinetic assessment * Blood donation within 8 weeks prior to study enrollment * Participation in another interventional clinical study within a timeframe that could interfere with study results or participant safety * Any condition or circumstance that, in the judgment of the study investigator, would make participation unsafe or compromise data integrity